Skip to content

H2020FP7EDFHORIZON

Etablissement Francais du Sang

Country
FRFrance
Defence projects
1
Projects, all programmes
14
As coordinator
1
EU contribution (CORDIS)
EUR 8,842,114
Active
2009 to 2025

Projects

14 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
RESILIENCE-D-25Second development SGA action for Medical Counter Measures against CBRN threats performed in the frame of the RESILIENCE FPA consortiumEDF2025ParticipantNot stated
ORTHO-ALLO-UNIONORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non-union (ORTHO-ALLO-UNION).HORIZON2023ParticipantEUR 933,561
EVIDENCEErythrocytes properties and viability in dependence of flow and extra-cellular environmentH20202020ParticipantEUR 274,802
SUPPORT-ESUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT EuropeH20202020ParticipantEUR 173,793
MEFISTOMEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomyH20202019ParticipantEUR 216,875
MAXIBONEPersonalised maxillofacial bone regenerationH20202018ParticipantEUR 1,615,439
ORTHOUNIONORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONsH20202017ParticipantEUR 394,743
RESSTOREREgenerative Stem cell therapy for STroke in EuropeH20202015ParticipantEUR 799,718
BIOCAPANBIOactive implantable CApsule for PANcreatic islets immunosuppression free therapyH20202015ParticipantEUR 652,940
ADIPOA2Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritisH20202015ParticipantEUR 890,430
Ebola_TxEmergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.H20202014ParticipantEUR 385,775
REBORNERegenerating Bone defects using New biomedical Engineering approachesFP72010ParticipantEUR 1,439,351
ADIPOAADIPOSE DERIVED STROMAL CELLS FOR OSTEOARTHRITISFP72010ParticipantEUR 634,687
CASCADECultivated Adult Stem Cells as Alternative for Damaged tissueFP72009CoordinatorEUR 430,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.